These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20140818)

  • 1. Malaria vaccines - The long synthetic peptide approach: Technical and conceptual advancements.
    Olugbile S; Habel C; Servis C; Spertini F; Verdini A; Corradin G
    Curr Opin Mol Ther; 2010 Feb; 12(1):64-76. PubMed ID: 20140818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malaria vaccine development using synthetic peptides as a technical platform.
    Corradin G; Céspedes N; Verdini A; Kajava AV; Arévalo-Herrera M; Herrera S
    Adv Immunol; 2012; 114():107-49. PubMed ID: 22449780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of two long synthetic merozoite surface protein 2 peptides as malaria vaccine candidates.
    Flueck C; Frank G; Smith T; Jafarshad A; Nebie I; Sirima SB; Olugbile S; Alonso P; Tanner M; Druilhe P; Felger I; Corradin G
    Vaccine; 2009 May; 27(20):2653-61. PubMed ID: 19428875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malaria vaccine.
    Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic GPI array to study antitoxic malaria response.
    Kamena F; Tamborrini M; Liu X; Kwon YU; Thompson F; Pluschke G; Seeberger PH
    Nat Chem Biol; 2008 Apr; 4(4):238-40. PubMed ID: 18311131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines.
    Patarroyo ME; Patarroyo MA
    Acc Chem Res; 2008 Mar; 41(3):377-86. PubMed ID: 18266328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant activity of polymer microparticles and Montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice.
    Mata E; Carcaboso AM; Hernández RM; Igartua M; Corradin G; Pedraz JL
    Vaccine; 2007 Jan; 25(5):877-85. PubMed ID: 17070628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High non-protective, long-lasting antibody levels in malaria are associated with haplotype shifting in MHC-peptide-TCR complex formation: a new mechanism for immune evasion.
    Patarroyo ME; Bermúdez A; Salazar LM; Espejo F
    Biochimie; 2006 Jul; 88(7):775-84. PubMed ID: 16483708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of human vaccine research and development: malaria.
    Girard MP; Reed ZH; Friede M; Kieny MP
    Vaccine; 2007 Feb; 25(9):1567-80. PubMed ID: 17045367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.
    Patarroyo ME; Amador R; Clavijo P; Moreno A; Guzman F; Romero P; Tascon R; Franco A; Murillo LA; Ponton G
    Nature; 1988 Mar; 332(6160):158-61. PubMed ID: 2450281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of protective immunity against experimental infection with malaria using synthetic peptides.
    Patarroyo ME; Romero P; Torres ML; Clavijo P; Moreno A; Martínez A; Rodríguez R; Guzman F; Cabezas E
    Nature; 1987 Aug 13-19; 328(6131):629-32. PubMed ID: 3302727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic peptides in malaria research.
    Ramasamy R
    Pept Res; 1991; 4(4):210-9. PubMed ID: 1823600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
    Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria.
    Schofield L; Hewitt MC; Evans K; Siomos MA; Seeberger PH
    Nature; 2002 Aug; 418(6899):785-9. PubMed ID: 12181569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria vaccines: if at first you don't succeed..
    Tongren JE; Zavala F; Roos DS; Riley EM
    Trends Parasitol; 2004 Dec; 20(12):604-10. PubMed ID: 15522671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective immunization with invariant peptides of the Plasmodium falciparum antigen MSA2.
    Saul A; Lord R; Jones GL; Spencer L
    J Immunol; 1992 Jan; 148(1):208-11. PubMed ID: 1727867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atomic evidence that modification of H-bonds established with amino acids critical for host-cell binding induces sterile immunity against malaria.
    Patarroyo ME; Cifuentes G; Piraján C; Moreno-Vranich A; Vanegas M
    Biochem Biophys Res Commun; 2010 Apr; 394(3):529-35. PubMed ID: 20206601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites.
    Herrington DA; Clyde DF; Losonsky G; Cortesia M; Murphy JR; Davis J; Baqar S; Felix AM; Heimer EP; Gillessen D
    Nature; 1987 Jul 16-22; 328(6127):257-9. PubMed ID: 2439920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.